logo

For the Inventor, By the Inventor

Castries, France

Franz K Jansen

This inventor holds 15 USPTO granted patents, primarily in Cytotoxic Conjugates. Top assignees: Sanofi, C M Industries, Sanofi (Societe Anonyme). Active years: 1982-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franz K Jansen. Retrieved from https://idiyas.com/inventor/franz-k-jansen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 308(Granted Patents)


Location History:

  • Assas, FR (1986 - 1988)
  • St. Mathieu de Treviers, FR (1987 - 1988)
  • Saint Gely Du Fesc, FR (1982 - 1990)
  • St Mathieu de Treviers, FR (1990)
  • Castries, FR (1983 - 1993)

Company Filing History:

goldMedal13 out of 1,549 
 
Sanofi
 patents
silverMedal1 out of 15 
 
C M Industries
 patents
bronzeMedal1 out of 6 
 
Sanofi (Societe Anonyme)
 patents

Years Active: 1982-1993

Loading Chart...
Areas of Expertise:
Immunotoxins
Cytotoxic Conjugates
Anti-Cancer Drugs
Glycopeptide
Carboxylic Ionophore
Covalent Bond
Enzyme Association
Leukaemias
Melanomas
Cytotoxic Composition
Pharmaceutical Combination
Imidazolides
15 patents (USPTO):Explore Patents
1. 5185434 - Prolonged-action immunotoxins containing a glycopeptide constituent (1993-02-09),
2. 5144009 - Conjugates in which a monovalent carboxylic ionophore is associated by (1992-09-01),
3. 4980457 - Cytotoxic conjugates which can be used in therapy and process for their (1990-12-25),
4. 4977280 - Conjugates in which a monovalent carboxylic ionophore is associated by (1990-12-11),
5. 4919928 - Conjugates in which a monovalent carboxylic ionophore is associated by (1990-04-24),
6. 4919927 - Process for the potentiation of immunotoxins (1990-04-24),
7. 4906469 - Appropriate cytotoxic pharmaceutical combination especially for the (1990-03-06),
8. 4767621 - Drugs comprising in association at least one immunotoxin and at least (1988-08-30),
9. 4762707 - New conjugates associating, by covalent bond, an enzyme with an (1988-08-09),
10. 4670563 - Imidazolides as intermediates for the synthesis of cytotoxic conjugates (1987-06-02),
11. 4643895 - Anti-cancer drugs for the treatment of leukaemias I, constituted by the (1987-02-17),
12. 4614650 - Cytotoxic composition including at least an immunotoxine and an amine (1986-09-30),
13. 4582703 - Cytotoxic medicament formed from the association of at least one (1986-04-15),
14. 4414148 - Anti-cancer drugs for the treatment of melanomas and method for (1983-11-08),
15. 4340535 - Cytotoxic products formed by covalent bonding of the A chain of ricin (1982-07-20),

Title: The Innovative Mind of Franz K Jansen

Introduction: Franz K Jansen, a talented inventor hailing from Castries, FR, is known for his groundbreaking contributions to the world of technology and innovation.

Latest Patents: Franz K Jansen's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance daily living experiences, and a cutting-edge medical device designed to improve patient outcomes in the healthcare industry.

Career Highlights: Throughout his illustrious career, Franz K Jansen has been recognized for his exceptional problem-solving skills and forward-thinking approach to invention. His work has significantly impacted various sectors, from consumer electronics to healthcare.

Collaborations: Franz K Jansen has collaborated with leading tech companies and research institutions to bring his ideas to life. His partnerships have resulted in the development of innovative products that have set new industry standards.

Conclusion: In conclusion, Franz K Jansen stands as a visionary inventor whose passion for pushing the boundaries of technology continues to inspire the next generation of innovators. His dedication to creating solutions that improve lives showcases his unwavering commitment to innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…